2 hours BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at ScotiabankMarketBeat
Scotiabank initiated coverage on shares of BridgeBio Pharma in a research report on Wednesday. They set a “sector outperform” rating on the stock.
Nasdaq 100 · Science · Scotiabank
X